| RS104894673 |
CRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 7, Retinal dystrophy |
| RS104894675 |
DLL3
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 1, autosomal recessive |
| RS104894676 |
DLL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondylocostal dysostosis 1, autosomal recessive |
| RS104894677 |
ETFB
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric acidemia IIb, Multiple acyl-CoA dehydrogenase deficiency |
| RS104894678 |
ETFB
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric acidemia IIb, Multiple acyl-CoA dehydrogenase deficiency |
| RS104894679 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development) |
| RS104894680 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development) |
| RS104894681 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
| RS104894682 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS104894683 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS104894684 |
FKRP
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
| RS104894685 |
FTL
|
Health Risk |
Pathogenic |
Neuroferritinopathy, Neuroferritinopathy |
| RS104894687 |
FUT1
|
Health Risk |
Pathogenic |
Para-Bombay phenotype, Para-Bombay phenotype |
| RS104894688 |
FUT1
|
Health Risk |
Pathogenic |
Para-Bombay phenotype, Para-Bombay phenotype |
| RS104894689 |
FKRP
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Autosomal recessive limb-girdle muscular dystrophy type 2I |
| RS104894691 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS104894692 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
| RS104894694 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS104894695 |
HAMP
|
Health Risk |
Pathogenic |
Hemochromatosis type 2B, Hemochromatosis type 2B |
| RS104894697 |
INSL3
|
Health Risk |
Pathogenic |
Cryptorchidism, Cryptorchidism |
| RS104894698 |
INSL3
|
Health Risk |
Pathogenic |
Cryptorchidism, Cryptorchidism |
| RS104894699 |
KCNC3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 13, Hereditary ataxia |
| RS104894700 |
KCNC3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 13, Spinocerebellar ataxia type 13 |
| RS104894701 |
KISS1R
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 8 without anosmia, Hypogonadotropic hypogonadism 8 without anosmia |
| RS104894702 |
KISS1R
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypogonadotropic hypogonadism 8 without anosmia, KISS1R-related disorder |
| RS104894703 |
KISS1R
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypogonadotropic hypogonadism 8 without anosmia, Central precocious puberty 1 |
| RS104894704 |
KLK4
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 2A1, Amelogenesis imperfecta type 2A1 |
| RS104894705 |
NDUFS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 3 |
| RS104894706 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease |
| RS104894707 |
PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease type 4 |
| RS104894708 |
PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 4F |
| RS104894709 |
RFXANK
|
Health Risk |
Pathogenic/Likely pathogenic |
MHC class II deficiency, MHC class II deficiency 2 |
| RS104894711 |
RPS19
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia |
| RS104894714 |
PRX
|
Health Risk |
Pathogenic |
Autosomal recessive Dejerine-Sottas syndrome, Charcot-Marie-Tooth disease type 4F |
| RS104894715 |
PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Dejerine-Sottas syndrome, Charcot-Marie-Tooth disease type 4 |
| RS104894716 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia |
| RS104894717 |
RPS19
|
Health Risk |
Pathogenic |
— |
| RS104894718 |
SCN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS104894719 |
TGFB1
|
Health Risk |
Pathogenic |
Diaphyseal dysplasia, Diaphyseal dysplasia |
| RS104894720 |
TGFB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Diaphyseal dysplasia, Inborn genetic diseases |
| RS104894721 |
TGFB1
|
Health Risk |
Pathogenic |
Diaphyseal dysplasia, See cases |
| RS104894722 |
TGFB1
|
Health Risk |
Pathogenic |
Diaphyseal dysplasia, Diaphyseal dysplasia |
| RS104894724 |
TNNI3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 7, Cardiovascular phenotype |
| RS104894725 |
TNNI3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy 7 |
| RS104894727 |
TNNI3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 7, Primary familial hypertrophic cardiomyopathy |
| RS104894728 |
TNNI3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial restrictive |
| RS104894729 |
TNNI3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial restrictive |
| RS104894730 |
TNNI3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial restrictive |
| RS104894732 |
TYROBP
|
Health Risk |
Pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 |
| RS104894733 |
AMELX
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1E, Amelogenesis imperfecta type 1E |
| RS104894734 |
AMELX
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1E, Amelogenesis imperfecta type 1E |
| RS104894735 |
AP1S2
|
Health Risk |
Pathogenic |
Pettigrew syndrome, Pettigrew syndrome |
| RS104894736 |
AMELX
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1E, AMELX-related disorder |
| RS104894737 |
AMELX
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1E, Amelogenesis imperfecta type 1E |
| RS104894738 |
AMELX
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1E, Amelogenesis imperfecta type 1E |
| RS104894739 |
AP1S2
|
Health Risk |
Pathogenic |
Pettigrew syndrome, Pettigrew syndrome |
| RS104894740 |
ARX
|
Health Risk |
Pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS104894741 |
ARX
|
Health Risk |
Pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS104894742 |
AR
|
Health Risk |
Pathogenic |
Partial androgen insensitivity syndrome, Partial androgen insensitivity syndrome |
| RS104894743 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS104894745 |
ARX
|
Health Risk |
Pathogenic |
Corpus callosum agenesis-abnormal genitalia syndrome, epileptic encephalopathy |
| RS104894746 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydranencephaly with abnormal genitalia, Developmental and epileptic encephalopathy |
| RS104894747 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894748 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894749 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894750 |
AVPR2
|
Health Risk |
Likely pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894751 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894752 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894753 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894754 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894755 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894756 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894757 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894758 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894759 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894760 |
AVPR2
|
Health Risk |
Likely pathogenic |
Diabetes insipidus, nephrogenic |
| RS104894761 |
AVPR2
|
Health Risk |
Likely pathogenic |
Nephrogenic syndrome of inappropriate antidiuresis, Nephrogenic diabetes insipidus |
| RS104894763 |
BMP15
|
Health Risk |
Conflicting classifications of pathogenicity |
Premature ovarian failure 4, Ovarian dysgenesis 2 |
| RS104894764 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS104894765 |
BMP15
|
Health Risk |
Pathogenic |
Ovarian dysgenesis 2, Ovarian dysgenesis 2 |
| RS104894766 |
BMP15
|
Health Risk |
Conflicting classifications of pathogenicity |
Premature ovarian failure 4, Ovarian dysgenesis 2 |
| RS104894767 |
BMP15
|
Health Risk |
Conflicting classifications of pathogenicity |
Premature ovarian failure 4, Ovarian dysgenesis 2 |
| RS104894768 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894769 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894770 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS104894771 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894774 |
CD40LG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894775 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894776 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894777 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894778 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS104894779 |
DCX
|
Health Risk |
Pathogenic/Likely pathogenic |
Subcortical laminar heterotopia, X-linked |
| RS104894780 |
DCX
|
Health Risk |
Pathogenic/Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Subcortical laminar heterotopia |
| RS104894781 |
DCX
|
Health Risk |
Pathogenic |
Subcortical laminar heterotopia, X-linked |
| RS104894782 |
DCX
|
Health Risk |
Pathogenic |
Subcortical laminar heterotopia, X-linked |
| RS104894784 |
DCX
|
Health Risk |
Pathogenic |
Subcortical laminar heterotopia, X-linked |
| RS104894785 |
DCX
|
Health Risk |
Pathogenic |
Subcortical laminar heterotopia, X-linked |
| RS104894786 |
DCX
|
Health Risk |
Conflicting classifications of pathogenicity |
Subcortical laminar heterotopia, X-linked |
| RS104894787 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS104894788 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |